Purchase Order VA24717P0292

Award Date 11/25/16
Potential Completion Date 2/27/17
Potential Value $83K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Columbia, SC 29209, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price purchase order was awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to Genmark Diagnostics, Inc. for the provision of HCV Genotyping Test Kits. The $109,172.93 contract has a completion date of December 21, 2016 and does not utilize a set-aside. Genmark Diagnostics is a manufacturer of molecular diagnostic testing equipment and supplies, including sample-to-answer systems for infectious disease and...
This firm fixed price purchase order was awarded by the Department of Veterans Affairs (VA) to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies, for GENMARK REAGENTS. The $81,292.44 contract has no set-aside designation and an ultimate completion date of March 26, 2018. Genmark Diagnostics holds several federal contract indefinite delivery vehicles (IDVs) with the VA to supply molecular diagnostic equipment and testing supplies, including a $1.15...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The $2,126,578.98 contract is for the provision of HCV (hepatitis C virus) genotype reagents to support testing and screening programs for veteran populations. The contract has no set-aside designation and is part of a larger $1.15 million blanket purchase agreement (BPA) and a $1.1 million BPA...
This is a $299,040 firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Genmark Diagnostics, Inc. for sensor assays. The contract has no set-aside designation. Genmark Diagnostics is a manufacturer of molecular diagnostic testing equipment and supplies, and has multiple federal contract vehicles with the VA, Department of Defense, and Department of Health and Human Services to provide diagnostic technologies, test kits, reagents, and related services, including...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The $94,021.58 contract is for the provision of reagents and test kits for the VA's XT machines. The award is set aside for small businesses. Genmark Diagnostics has a history of delivering molecular testing platforms, assays, and consumables to support genetic screening programs and infectious disease...
This firm fixed price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The contract, valued at $140,000.00, supports the VA's COVID-19 response efforts through the provision of Genmark's ePlex instrument and Respiratory Pathogen Panel tests to aid in detection of the virus. Genmark holds several federal IDVs and BPAs with the VA to supply...
This is a definitive contract awarded by the U.S. Department of Veterans Affairs (VA) to Genmark Diagnostics, Inc., a for-profit manufacturer of molecular diagnostic testing equipment and supplies. The $95,400.00 firm fixed price contract is for the maintenance of Genmark's diagnostic systems and related consumables provided to VA hospitals and clinics. The contract has no set-aside designation. Genmark has previously received other VA contracts, including blanket purchase agreements valued up...
This federal contract award from the Department of Veterans Affairs (VA) was issued to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The $286,631.50 firm fixed price purchase order is for Genmark's SENSOR XT-ANALYZER, with a completion date of June 8, 2024. Genmark Diagnostics has held several federal contracts and blanket purchase agreements (BPAs) with the VA to provide its ePlex molecular diagnostic instruments, SARS-CoV-2 test kits, and...
This federal contract award to Genmark Diagnostics, Inc. is a Blanket Purchase Agreement (BPA) from the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 19. The BPA, valued at $256,223.20, is for the procurement of eSensor RVP test and eSensor HCVG Direct test kits to support diagnostic testing at VHA facilities. The contract has a completion date of September 30, 2019 and is a firm fixed price contract with no set-aside designation. Genmark...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $105,000.00 firm fixed price purchase order to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The contract is for the purchase of a molecular analyzer and related reagents to support respiratory pathogen testing, with a completion date of November 30, 2022. Genmark Diagnostics provides diagnostic technologies, test kits, reagents, and related services to VA...

This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Genmark Diagnostics, Inc., a manufacturer of molecular diagnostic testing equipment and supplies. The contract provides for the delivery of Genmark's eSensor HCV Genotyping II Reagent Testing Kits to support diagnostic testing for the VA. The contract has a ceiling value of $83,137.54 and an ultimate completion date of February 27, 2017. Genmark Diagnostics holds several federal contract vehicles with the VA, including indefinite delivery contracts and blanket purchase agreements, to supply its molecular diagnostic equipment and testing supplies, including for COVID-19 testing, across the VA healthcare system. This particular contract does not have a set-aside designation.

Generated 4/1/25, 4:50 PM